GS-9973 reduced NETs formation by inhibiting the SYK/PKM2/P-STAT3 pathway in neutrophils and the NLRP3 inflammasome pathway dependent on IL-1β in macrophages, thereby alleviating hepatic IRI and liver cancer recurrence. The gene discussed is SYK; the disease is liver cancer.